Prakash Kharel

1.4k total citations · 1 hit paper
13 papers, 1.0k citations indexed

About

Prakash Kharel is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Prakash Kharel has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in Prakash Kharel's work include Multiple Myeloma Research and Treatments (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Prakash Kharel is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Prakash Kharel collaborates with scholars based in United States, France and Greece. Prakash Kharel's co-authors include Abhinav Chandra, Ramesh Kumar Pandey, Raju Vaddepally, Rohan Garje, Smith Giri, Alyssa Grimshaw, Thierry Façon, María‐Victoria Mateos, Susan Bal and Benjamin Djulbegović and has published in prestigious journals such as Journal of Clinical Oncology, Blood and CHEST Journal.

In The Last Decade

Prakash Kharel

11 papers receiving 1.0k citations

Hit Papers

Review of Indications of FDA-Approved Immune Checkpoint I... 2020 2026 2022 2024 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
    2020 895 citations Raju Vaddepally, Prakash Kharel et al. Cancers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prakash Kharel United States 6 739 342 249 205 102 13 1.0k
Yavar Shiravand Italy 7 493 0.7× 285 0.8× 214 0.9× 147 0.7× 75 0.7× 9 844
Xiaorui Fu China 19 605 0.8× 374 1.1× 360 1.4× 129 0.6× 84 0.8× 91 1.2k
Mark Cornfeld United States 11 497 0.7× 157 0.5× 294 1.2× 151 0.7× 127 1.2× 33 838
Troy Z. Horvat United States 8 966 1.3× 312 0.9× 252 1.0× 231 1.1× 146 1.4× 18 1.2k
Saleh Rachidi United States 16 544 0.7× 305 0.9× 454 1.8× 105 0.5× 104 1.0× 27 1.2k
Ernest Marshall United Kingdom 17 482 0.7× 209 0.6× 287 1.2× 232 1.1× 66 0.6× 42 938
Sheng Yang China 16 406 0.5× 192 0.6× 149 0.6× 196 1.0× 63 0.6× 105 781
Raju Vaddepally United States 5 745 1.0× 352 1.0× 202 0.8× 246 1.2× 23 0.2× 10 997
Corrine Zarwan United States 13 691 0.9× 226 0.7× 321 1.3× 200 1.0× 40 0.4× 27 1.1k

Countries citing papers authored by Prakash Kharel

Since Specialization
Citations

This map shows the geographic impact of Prakash Kharel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prakash Kharel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prakash Kharel more than expected).

Fields of papers citing papers by Prakash Kharel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prakash Kharel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prakash Kharel. The network helps show where Prakash Kharel may publish in the future.

Co-authorship network of co-authors of Prakash Kharel

This figure shows the co-authorship network connecting the top 25 collaborators of Prakash Kharel. A scholar is included among the top collaborators of Prakash Kharel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prakash Kharel. Prakash Kharel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Grimshaw, Alyssa, Prakash Kharel, Susan Bal, et al.. (2024). Low skeletal muscle mass and treatment outcomes among adults with haematologic malignancies: A systematic review and meta‐analysis. Journal of Cachexia Sarcopenia and Muscle. 15(3). 1084–1093. 6 indexed citations
3.
4.
Giri, Smith, Alyssa Grimshaw, Susan Bal, et al.. (2020). Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors. JAMA Oncology. 6(11). 1759–1759. 67 indexed citations
5.
Kharel, Prakash, et al.. (2020). Neratinib-Induced Duodenal Ulcer: A Case Report. Breast Cancer Basic and Clinical Research. 14. 2222493375–2222493375.
6.
Vaddepally, Raju, Prakash Kharel, Ramesh Kumar Pandey, Rohan Garje, & Abhinav Chandra. (2020). Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence. Cancers. 12(3). 738–738. 895 indexed citations breakdown →
7.
Giri, Smith, Alyssa Grimshaw, Susan Bal, et al.. (2020). Efficacy of daratumumab in the treatment of multiple myeloma with high-risk cytogenetics: Meta-analysis of randomized phase III trials.. Journal of Clinical Oncology. 38(15_suppl). 8540–8540. 8 indexed citations
8.
Kharel, Prakash, et al.. (2019). Hematologic Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Systematic Review of Case-Reports and Case-Series. Blood. 134(Supplement_1). 3606–3606. 4 indexed citations
9.
Kharel, Prakash, et al.. (2019). Copper Deficiency and Cytopenia: A Systematic Review. Blood. 134(Supplement_1). 5025–5025. 3 indexed citations
10.
Kharel, Prakash, et al.. (2018). Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature. Case Reports in Medicine. 2018. 1–5. 18 indexed citations
11.
Ghosh, Meenakshi, et al.. (2014). Leukocytosis in Patients With COPD/BA Exacerbation: Steroid-Induced or Sign of an Infection?. CHEST Journal. 146(4). 28A–28A. 1 indexed citations
12.
Kharel, Prakash, et al.. (2012). Isolation, Identification and Antimicrobial Activity of a Withanolide [WS-1] from the Roots of Withania somnifera. Nepal Journal of Science and Technology. 12. 179–186. 5 indexed citations
13.
Kharel, Prakash, et al.. (1970). Clinical profile of patients with pleural effusion admitted to KMCTH. Kathmandu University Medical Journal. 7(4). 438–444. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yavar Shiravand Breakdown of academic impact, for papers by Xiaorui Fu Breakdown of academic impact, for papers by Mark Cornfeld Breakdown of academic impact, for papers by Troy Z. Horvat Breakdown of academic impact, for papers by Saleh Rachidi Breakdown of academic impact, for papers by Ernest Marshall Breakdown of academic impact, for papers by Sheng Yang Breakdown of academic impact, for papers by Raju Vaddepally Breakdown of academic impact, for papers by Corrine Zarwan
Rankless by CCL
2026